171 related articles for article (PubMed ID: 35127392)
1. The osteogenic niche-targeted arsenic nanoparticles prevent colonization of disseminated breast tumor cells in the bone.
Liu C; Hu A; Chen H; Liang J; Gu M; Xiong Y; Mu CF
Acta Pharm Sin B; 2022 Jan; 12(1):364-377. PubMed ID: 35127392
[TBL] [Abstract][Full Text] [Related]
2. Dual oligopeptides modification mediates arsenic trioxide containing nanoparticles to eliminate primitive chronic myeloid leukemia cells inside bone marrow niches.
Fan L; Liu C; Hu A; Liang J; Li F; Xiong Y; Mu CF
Int J Pharm; 2020 Apr; 579():119179. PubMed ID: 32112927
[TBL] [Abstract][Full Text] [Related]
3. The Endosteal Niche in Breast Cancer Bone Metastasis.
Haider MT; Smit DJ; Taipaleenmäki H
Front Oncol; 2020; 10():335. PubMed ID: 32232008
[TBL] [Abstract][Full Text] [Related]
4. The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability.
Wang H; Tian L; Liu J; Goldstein A; Bado I; Zhang W; Arenkiel BR; Li Z; Yang M; Du S; Zhao H; Rowley DR; Wong STC; Gugala Z; Zhang XH
Cancer Cell; 2018 Nov; 34(5):823-839.e7. PubMed ID: 30423299
[TBL] [Abstract][Full Text] [Related]
5. Bone as a Preferential Site for Metastasis.
Sowder ME; Johnson RW
JBMR Plus; 2019 Mar; 3(3):e10126. PubMed ID: 30918918
[TBL] [Abstract][Full Text] [Related]
6. Bone Metastasis: Find Your Niche and Fit in.
Zhang W; Bado I; Wang H; Lo HC; Zhang XH
Trends Cancer; 2019 Feb; 5(2):95-110. PubMed ID: 30755309
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicle-Packaged CDH11 and ITGA5 Induce the Premetastatic Niche for Bone Colonization of Breast Cancer Cells.
Li XQ; Zhang R; Lu H; Yue XM; Huang YF
Cancer Res; 2022 Apr; 82(8):1560-1574. PubMed ID: 35149589
[TBL] [Abstract][Full Text] [Related]
8. Mapping bone marrow niches of disseminated tumor cells.
Zhang W; Lo HC; Zhang XH
Sci China Life Sci; 2017 Oct; 60(10):1125-1132. PubMed ID: 29027156
[TBL] [Abstract][Full Text] [Related]
9. Bone metastasis and the metastatic niche.
Ren G; Esposito M; Kang Y
J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
[TBL] [Abstract][Full Text] [Related]
10. In vitro design of mesenchymal to epithelial transition of prostate cancer metastasis using 3D nanoclay bone-mimetic scaffolds.
Molla MS; Katti DR; Katti KS
J Tissue Eng Regen Med; 2018 Mar; 12(3):727-737. PubMed ID: 28603879
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow/bone pre-metastatic niche for breast cancer cells colonization: The role of mesenchymal stromal cells.
Sanmartin MC; Borzone FR; Giorello MB; Pacienza N; Yannarelli G; Chasseing NA
Crit Rev Oncol Hematol; 2021 Aug; 164():103416. PubMed ID: 34237436
[TBL] [Abstract][Full Text] [Related]
12. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells.
Zhang W; Xu Z; Hao X; He T; Li J; Shen Y; Liu K; Gao Y; Liu J; Edwards DG; Muscarella AM; Wu L; Yu L; Xu L; Chen X; Wu YH; Bado IL; Ding Y; Aguirre S; Wang H; Gugala Z; Satcher RL; Wong STC; Zhang XH
Cancer Discov; 2023 Feb; 13(2):474-495. PubMed ID: 36287038
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
[TBL] [Abstract][Full Text] [Related]
14. Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells.
Dhawan A; von Bonin M; Bray LJ; Freudenberg U; Pishali Bejestani E; Werner C; Hofbauer LC; Wobus M; Bornhäuser M
Stem Cells; 2016 Aug; 34(8):2224-35. PubMed ID: 27090603
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cells compete with hematopoietic stem and progenitor cells for intercellular adhesion molecule 1-mediated binding to the bone marrow microenvironment.
Dhawan A; Friedrichs J; Bonin MV; Bejestani EP; Werner C; Wobus M; Chavakis T; Bornhäuser M
Carcinogenesis; 2016 Aug; 37(8):759-767. PubMed ID: 27207667
[TBL] [Abstract][Full Text] [Related]
17. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
18. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.
Wang H; Yu C; Gao X; Welte T; Muscarella AM; Tian L; Zhao H; Zhao Z; Du S; Tao J; Lee B; Westbrook TF; Wong ST; Jin X; Rosen JM; Osborne CK; Zhang XH
Cancer Cell; 2015 Feb; 27(2):193-210. PubMed ID: 25600338
[TBL] [Abstract][Full Text] [Related]
19. The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche
Allocca G; Hughes R; Wang N; Brown HK; Ottewell PD; Brown NJ; Holen I
J Bone Oncol; 2019 Aug; 17():100244. PubMed ID: 31236323
[TBL] [Abstract][Full Text] [Related]
20. CD8
Monteiro AC; Bonomo A
Bone; 2021 Sep; 150():116014. PubMed ID: 34022456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
